Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre- versus postmenopausal women

Deibert, Peter; König, Daniel; Vitolins, Mara Z.; Landmann, U.; Frey, Ingrid; Zahradnik, H. P.; Berg, Aloys

doi:10.1186/1475-2891-6-31

Cited by 89 publications

(86 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There are also other studies in which the results are different from this one. The prevalence in the studies carried out in Austria (16), Germany (17), and Canada (18) was 32.6%, 36.1%, and 29.6%, respectively.…”

Section: Discussionmentioning

confidence: 99%

“…The treatment should include weight loss programs, regular physical exercise, and diet changes. There are studies indicating a 58% decrease in metabolic syndrome and diabetes incidence by losing 5% weight through regular exercise (31)(32)(33). Although a therapeutic lifestyle change is the first line of treatment for metabolic syndrome, it may be necessary to add antihypertensive and antilipidemic agents for the purpose of individual cardiac risk factor administration (34).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of Metabolic Syndrome and Effect of Hormone Profile in Postmenopausal Patients

Şahin¹,

Salman²,

Ayanoğlu³

et al. 2016

JAREM

View full text Add to dashboard Cite

Objective: The purpose of this study was to evaluate the prevalence and connection with hormonal changes of metabolic syndrome and its components in postmenopausal women based on a literature survey. Methods:The medical records of 138 postmenopausal patients were retrospectively reviewed between January 2013 and March 2014. Patients with surgical menopause and those who underwent hormone replacement therapy, chemotherapy, and radiotherapy were excluded. Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. Patients' demographic data, menopausal status, medical history, and physical examination and clinical laboratory data were analyzed. Data were evaluated statistically.Results: In total, 128 patients were included in this study. The menopausal age of patients in the metabolic syndrome group was 50.06±2.93 and that in the non-metabolic syndrome group was 45.16±4.4 years. The prevalence of metabolic syndrome was observed in 43.4% patients in this study. A statistically significant negative high correlation (p<0.05) was observed between waist circumference and the number of metabolic components with FSH-LH levels. Conclusion:The prevalence of metabolic syndrome among postmenopausal women is high, and abdominal obesity and low HDL levels are strong predictors. These components can lead to an increase in cardiovascular diseases. Thus, it is encouraging to adopt lifestyle changes that reduce the prevalence of metabolic syndrome. (JAREM 2016; 6: 35-9)

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Prevalence of Metabolic Syndrome and Effect of Hormone Profile in Postmenopausal Patients

Şahin¹,

Salman²,

Ayanoğlu³

et al. 2016

JAREM

View full text Add to dashboard Cite

show abstract

“…A weight loss of 5-10% of initial body weight improves metabolic profile (Ratner et al, 2005;Deibert et al, 2007;Phelan et al, 2007) and reduces the incidence of type II diabetes (Knowler et al, 2002). Furthermore, results from the Diabetes Prevention Program have shown that for every kg of weight loss, there was a 16% decrease in type II diabetes risk, emphasizing the beneficial effect of very modest weight losses (Hamman et al, 2006).…”

Section: Introductionmentioning

confidence: 99%

Using restrictive messages to limit high-fat foods or nonrestrictive messages to increase fruit and vegetable intake: what works better for postmenopausal women?

et al. 2009

View full text Add to dashboard Cite

Background/Objectives: To compare the effects of two dietary approaches on changes in dietary intakes and body weight: (1) an approach emphasizing nonrestrictive messages directed toward the inclusion of fruits and vegetables (HIFV) and (2) another approach using restrictive messages to limit high-fat foods (LOFAT). Subjects/Methods: A total of 68 overweight-obese postmenopausal women were randomly assigned to one of the two dietary approaches. The 6-month dietary intervention included three group sessions and ten individual sessions with a dietitian. Dietary food intake and anthropometric variables were measured at baseline, at 3 months and at 6 months. Results: Energy density decreased in both groups after the intervention compared with baseline (HIFV, À0.3±0.2 kcal/g; LOFAT, À0.3 ± 0.3 kcal/g; Po0.0001). Although body weight decreased significantly in both groups after the intervention compared with baseline (HIFV, À1.6±2.9 kg; LOFAT, À3.5±2.9 kg; Po0.0001), women in the LOFAT group lost significantly more body weight than women in the HIFV group (P ¼ 0.01). In the HIFV group, the decrease in energy density was found to be an independent predictor of body weight loss. Conclusions: The LOFAT approach induces more weight loss than does the HIFV approach in our sample of overweight-obese postmenopausal women.

show abstract

“…This may happen with high prevalence of metabolic syndrome among postmenopausal women. Study of Deibert et al [42] showed that prevalence of metabolic syndrome among post-menopausal women was 36.1% and also some other studies showed that menopausal women in Canada [43], Ecuador [33] and South Korea [44] had prevalence of metabolic syndrome 31%, 41.5% and 54.6% respectively. Marjani et al showed that the prevalence of metabolic syndrome among postmenopausal women was 31% [45].…”

Section: Different Viewsmentioning

confidence: 92%

“…Studies among Korean and Chinese populations showed that prevalence of metabolic syndrome were 13.8% [44] and 17.8% for females, respectively [50]. Studies were done by Eshtiaghi [51], Ainy [52], Deilbert [42], Figueiredo Neto [53] and Heidari et al [54] have shown that prevalence of metabolic syndrome were 18.3%, 53%, 23%, 24% and 44.9%, respectively. Studies in Greece and USA have shown that prevalence of metabolic syndrome was similar in both genders [9,55].…”

Section: Different Viewsmentioning

confidence: 99%

A Review on Metabolic Syndrome

Marjani

2012

J Endocrinol Metab

View full text Add to dashboard Cite

The metabolic syndrome is described by the clustering of several risk factors for Type 2 diabetes and cardiovascular disease. Lipid disorder, obesity, diabetes in general and high blood pressure are collectively defined as risk factors for cardiovascular disease triggered by metabolic syndrome. The metabolic syndromes have a correlation with the variations in genetic susceptibility, nutritional regiment, physical exercise, chronological age and gender which play direct role in the incidence of metabolic syndrome and its side effects. There are several definitions of Metabolic Syndrome in the World: World Health Organization's (WHO), The NCEP Adult Treatment Panel (ATP) III and the International Diabetes Federation (IDF). It appears that the female type 2 diabetic patients need to change their life style to halt the burden of cardiovascular complications in type 2 diabetic patients. Clinicians should significantly consider screening all people regardless of age for abnormalities in glucose level. Early treatment in people with abnormal glucose level constitutes a strategy of preventing type 2 diabetes mellitus and metabolic syndrome. Studies about metabolic syndrome have shown that females were more affected than males. This may be due to the specific characteristics in the lifestyle changes between females and males diabetic patients. Postmenopausal status might be a predictor of metabolic syndrome. Some related factors of metabolic syndrome among postmenopausal women may increase cardiovascular risk in postmenopausal women.

show abstract

Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre- versus postmenopausal women

Abstract: Background: The present study examines changes in body weight, fat mass, metabolic and hormonal parameters in overweight and obese pre-and postmenopausal women who participated in a weight loss intervention.

Cited by 89 publications

References 29 publications

Prevalence of Metabolic Syndrome and Effect of Hormone Profile in Postmenopausal Patients

Prevalence of Metabolic Syndrome and Effect of Hormone Profile in Postmenopausal Patients

Using restrictive messages to limit high-fat foods or nonrestrictive messages to increase fruit and vegetable intake: what works better for postmenopausal women?

A Review on Metabolic Syndrome

Contact Info

Product

Resources

About